ERBA MIKROLATEST® MIC - BP
MIKROLATEST® BP-Kits
MIKROLATEST® BP kits are antibiotic susceptibility testing (AST) panels based on bacterial growth in breakpoint concentrations of defined antibiotics. Breakpoints refer to standards of the European Committee for Antimicrobial Susceptibility Testing – EUCAST issued in January 2011. Most of the antibiotics are represented by two (in exceptional cases one or three) breakpoint concentrations, which enable interpretation into three categories: sensitive, intermediate or resistant.
These categories are characterised by EUCAST* as follows:
Microorganism is defined as sensitive by a level of antimicrobial activity associated with a high probability of therapeutic success. A microorganism is defined as intermediate by a level of antimicrobial activity associated with uncertain therapeutic effect. Microorganism is defined as resistant by a level of antimicrobial activity associated with a high probability of therapeutic failure.In each test system, there is a growth control.
Available Panels
SENSILATEST G-I
The kit is designed to test the antimicrobial susceptibility of bacteria from the Enterobacteriaceae family. The kit contains 60 detection strips. It enables the prognosis of ESBL production. We recommend using SENSILATEST G-I together with SENSILATEST G-II to test the susceptibility of antibiotics aimed at the treatment of serious infections, especially in hospitalised patients
SENSILATEST G-II
The kit is designed to test the antimicrobial susceptibility of bacteria from the Enterobacteriaceae family. It enables the prognosis of ESBL production. The antibiotics in this kit are aimed at the treatment of serious infections, especially in hospitalised patients. Antibiotics for less serious infections are included in the kit SENSILAtest G-I. The kit contains 60 detection strips.
SENSILATEST G+
The kit is designed to test antimicrobial susceptibility of Gram-positive bacteria: enterococci and A,B,C,G streptococci. The kit contains 40 detection strips.
SENSILATEST URINE
The kit is designed to test the antimicrobial susceptibility of bacteria isolated from the urinary tract, especially the family Enterobacteriaceae. It enables the prognosis of ESBL production. The kit contains 40 detection strips.
SENSILATEST NEFERM
The kit is designed to test the antimicrobial susceptibility of non-fermenting bacteria. It enables the prognosis of MBL (metallo-beta-lactamase) production. The kit contains 60 detection strips.
SENSILATEST STAPHY
The kit is designed to test the antimicrobial susceptibility of staphylococci. The possibility of MRSA is indicated. The kit contains 60 detection strips.
Ordering Information
MIKROLATEST® BP-Kits
MIKROLATEST® BP kits are antibiotic susceptibility testing (AST) panels based on bacterial growth in breakpoint concentrations of defined antibiotics. Breakpoints refer to standards of the European Committee for Antimicrobial Susceptibility Testing – EUCAST issued in January 2011. Most of the antibiotics are represented by two (in exceptional cases one or three) breakpoint concentrations, which enable interpretation into three categories: sensitive, intermediate or resistant.
These categories are characterised by EUCAST* as follows:
Microorganism is defined as sensitive by a level of antimicrobial activity associated with a high probability of therapeutic success. A microorganism is defined as intermediate by a level of antimicrobial activity associated with uncertain therapeutic effect. Microorganism is defined as resistant by a level of antimicrobial activity associated with a high probability of therapeutic failure.In each test system, there is a growth control.
Available Panels
SENSILATEST G-I
The kit is designed to test the antimicrobial susceptibility of bacteria from the Enterobacteriaceae family. The kit contains 60 detection strips. It enables the prognosis of ESBL production. We recommend using SENSILATEST G-I together with SENSILATEST G-II to test the susceptibility of antibiotics aimed at the treatment of serious infections, especially in hospitalised patients
SENSILATEST G-II
The kit is designed to test the antimicrobial susceptibility of bacteria from the Enterobacteriaceae family. It enables the prognosis of ESBL production. The antibiotics in this kit are aimed at the treatment of serious infections, especially in hospitalised patients. Antibiotics for less serious infections are included in the kit SENSILAtest G-I. The kit contains 60 detection strips.
SENSILATEST G+
The kit is designed to test antimicrobial susceptibility of Gram-positive bacteria: enterococci and A,B,C,G streptococci. The kit contains 40 detection strips.
SENSILATEST URINE
The kit is designed to test the antimicrobial susceptibility of bacteria isolated from the urinary tract, especially the family Enterobacteriaceae. It enables the prognosis of ESBL production. The kit contains 40 detection strips.
SENSILATEST NEFERM
The kit is designed to test the antimicrobial susceptibility of non-fermenting bacteria. It enables the prognosis of MBL (metallo-beta-lactamase) production. The kit contains 60 detection strips.
SENSILATEST STAPHY
The kit is designed to test the antimicrobial susceptibility of staphylococci. The possibility of MRSA is indicated. The kit contains 60 detection strips.
Ordering Information
